US equities
|
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
META
$720.89
▼-0.06%
SPCX
$160.57
▼-4.19%
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
META
$720.89
▼-0.06%
SPCX
$160.57
▼-4.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tandem Diabetes Care, Inc. - Common Stock
(NQ:
TNDM
)
15.68
-0.16 (-1.04%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Tandem Diabetes Care, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks
September 29, 2026
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
Via
StockStory
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
September 23, 2026
What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid S...
Via
StockStory
3 Cash-Burning Stocks with Questionable Fundamentals
September 18, 2026
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them...
Via
StockStory
Topics
Electric Vehicles
3 Reasons TNDM is Risky and 1 Stock to Buy Instead
August 25, 2026
Over the last six months, Tandem Diabetes’s shares have sunk to $22.45, producing a disappointing 13.7% loss - a stark contrast to the S&P 500’s 10.5% gain. ...
Via
StockStory
Topics
Stocks
Tandem Diabetes Care (NASDAQ:TNDM) Surges 10% After Q1 Beat on Revenue and Earnings
↗
May 07, 2026
Via
Chartmill
Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi
↗
August 18, 2026
Tandem Diabetes Care (NASDAQ:TNDM) highlighted its plans to expand insulin pump adoption through a shift to pharmacy distribution in the U.S., direct sales in additional international markets and...
Via
MarketBeat
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Pump shipments surged 10% as pharmacy adoption accelerated.
Via
The Motley Fool
Topics
Earnings
5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call
August 13, 2026
Tandem Diabetes met Wall Street’s revenue and profit expectations in Q2, but the market responded negatively, likely reflecting investor caution around the p...
Via
StockStory
Topics
Earnings
Why Tandem Diabetes (TNDM) Stock Is Trading Up Today
August 07, 2026
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 18.2% in the afternoon session after the company reported seco...
Via
StockStory
Topics
Artificial Intelligence
Tandem Diabetes Care Q2 Earnings Call Highlights
↗
August 07, 2026
Tandem Diabetes Care (NASDAQ:TNDM) reported second-quarter results that included record sales, pump shipments and gross margin for a second quarter, while management highlighted early progress in its...
Via
MarketBeat
Topics
Earnings
TNDM Q2 Deep Dive: Pharmacy Channel Gains and Pipeline Execution Amid Margin Recovery
August 07, 2026
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $254.6...
Via
StockStory
Topics
Economy
Tandem Diabetes’s (NASDAQ:TNDM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
August 06, 2026
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $254.6...
Via
StockStory
Topics
Artificial Intelligence
Tandem Diabetes Earnings: What To Look For From TNDM
August 04, 2026
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be announcing earnings results this Thursday after market close. Here’s what you need to ...
Via
StockStory
Topics
Artificial Intelligence
3 Stocks Under $50 We Steer Clear Of
July 27, 2026
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Via
StockStory
3 Healthcare Stocks with Questionable Fundamentals
July 23, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron...
Via
StockStory
1 Unprofitable Stock with Exciting Potential and 2 Facing Challenges
July 17, 2026
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Via
StockStory
Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks
July 15, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare technology ...
Via
StockStory
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Turn Down
July 09, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via
StockStory
Why Tandem Diabetes (TNDM) Shares Are Sliding Today
June 30, 2026
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 2.5% in the afternoon session after a new competitor, Modular Me...
Via
StockStory
1 Mooning Stock with Impressive Fundamentals and 2 We Find Risky
June 19, 2026
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u...
Via
StockStory
Topics
Stocks
Tandem Diabetes (TNDM): Buy, Sell, or Hold Post Q1 Earnings?
June 16, 2026
Tandem Diabetes has gotten torched over the last six months - since December 2025, its stock price has dropped 25.8% to $16.77 per share. This may have inves...
Via
StockStory
Why Is Tandem Diabetes (TNDM) Stock Soaring Today
June 01, 2026
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 13.8% in the afternoon session after Wells Fargo analysts upgr...
Via
StockStory
What to Know About This $18 Million Bet on a Rental Business With 35 Years of Dividend Growth
↗
May 31, 2026
McGrath RentCorp delivers modular buildings and equipment rentals to diverse institutional and industrial clients across multiple sectors.
Via
The Motley Fool
Topics
Regulatory Compliance
1 of Wall Street’s Favorite Stock on Our Buy List and 2 Facing Headwinds
May 20, 2026
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via
StockStory
3 Small-Cap Stocks We Keep Off Our Radar
May 18, 2026
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Via
StockStory
Tandem Diabetes’s Q1 Earnings Call: Our Top 5 Analyst Questions
May 14, 2026
Tandem Diabetes Care’s first quarter results were met with a positive market reaction, reflecting the company’s ability to exceed Wall Street’s revenue and G...
Via
StockStory
Topics
Earnings
3 Healthcare Stocks We’re Skeptical Of
May 11, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...
Via
StockStory
Tandem Diabetes Care Q1 Earnings Call Highlights
↗
May 09, 2026
Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward...
Via
MarketBeat
Topics
Earnings
Supply Chain
Why Tandem Diabetes (TNDM) Shares Are Trading Lower Today
May 08, 2026
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 10.9% in the afternoon session after the company's disappointing...
Via
StockStory
Topics
Artificial Intelligence
TNDM Q1 Deep Dive: Margin Expansion and Pipeline Advances Amid Business Model Shift
May 08, 2026
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.5% year on ...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
